270 related articles for article (PubMed ID: 7531753)
41. Characteristics of patients with dual infection by hepatitis B and C viruses.
Zarski JP; Bohn B; Bastie A; Pawlotsky JM; Baud M; Bost-Bezeaux F; Tran van Nhieu J; Seigneurin JM; Buffet C; Dhumeaux D
J Hepatol; 1998 Jan; 28(1):27-33. PubMed ID: 9537860
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
43. Clinical usefulness of an assay for hepatitis C virus core in the diagnosis of non-A, non-B hepatitis and monitoring of the response to interferon therapy.
Kawano S; Tanaka M; Fujiyama S; Sato S; Taura Y; Goto M; Chikazawa H; Sato T
J Gastroenterol Hepatol; 1994; 9(3):217-22. PubMed ID: 7519894
[TBL] [Abstract][Full Text] [Related]
44. Diagnosis of hepatitis C virus infection by enzyme-linked immunosorbent assay and reverse transcriptase-nested polymerase chain reaction: a comparative evaluation.
Swellam M; Mahmoud MS; Ali AA
IUBMB Life; 2011 Jun; 63(6):430-4. PubMed ID: 21557447
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
46. Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide.
Okamoto H; Munekata E; Tsuda F; Takahashi K; Yotsumoto S; Tanaka T; Tachibana K; Akahane Y; Sugai Y; Miyakawa Y
Jpn J Exp Med; 1990 Aug; 60(4):223-33. PubMed ID: 1963454
[TBL] [Abstract][Full Text] [Related]
47. Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors.
McCaughan GW; McGuinness PH; Bishop GA; Painter DM; Lien AS; Tulloch R; Wylie BR; Archer GT
Med J Aust; 1992 Aug; 157(4):231-3. PubMed ID: 1279365
[TBL] [Abstract][Full Text] [Related]
48. Suppression of hepatitis C virus by hepatitis B virus in coinfected patients at the National University Hospital of Singapore.
Wang YM; Ng WC; Lo SK
J Gastroenterol; 1999 Aug; 34(4):481-5. PubMed ID: 10452681
[TBL] [Abstract][Full Text] [Related]
49. A sensitive serodiagnosis of hepatitis C virus (HCV) infection with two non-fused peptides: comparison of antibody responses detected with a newly developed assay and a commercial second-generation test.
Sato A; Ida N; Ishikawa M; Tanahashi K; Nakamura H; Sho Y; Arima T; Kunitomo T
Microbiol Immunol; 1993; 37(4):295-304. PubMed ID: 7688847
[TBL] [Abstract][Full Text] [Related]
50. Viral markers in the treatment of hepatitis B and C.
Schmilovitz-Weiss H; Levy M; Thompson N; Dusheiko G
Gut; 1993; 34(2 Suppl):S26-35. PubMed ID: 7686114
[TBL] [Abstract][Full Text] [Related]
51. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B.
Villa E; Grottola A; Buttafoco P; Trande P; Merighi A; Fratti N; Seium Y; Cioni G; Manenti F
Dig Dis Sci; 1995 Jan; 40(1):8-13. PubMed ID: 7529674
[TBL] [Abstract][Full Text] [Related]
52. Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction.
Shieh YS; Shim KS; Lampertico P; Balart LA; Jeffers LJ; Thung SN; Regenstein F; Reddy KR; Farr G; Schiff ER
Lab Invest; 1991 Oct; 65(4):408-11. PubMed ID: 1656140
[TBL] [Abstract][Full Text] [Related]
53. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
54. Chronic liver disease and active hepatitis C virus infection in patients with antibodies to this virus.
Petrelli E; Manzin A; Paolucci S; Cioppi A; Brugia M; Muretto P; Clementi M
J Clin Pathol; 1994 Feb; 47(2):148-51. PubMed ID: 7510725
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the enzyme-linked immunosorbant assay III, recombinant immunoblot third generation assay, and polymerase chain reaction method in the detection of hepatitis C virus infection in haemodialysis patients.
Garinis G; Spanakis N; Theodorou V; Gorgoulis V; Manolis E; Karameris A; Valis D
J Clin Lab Anal; 1999; 13(3):122-5. PubMed ID: 10323477
[TBL] [Abstract][Full Text] [Related]
56. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
Crespo J; Dueñas C; Sánchez-Antolín G; Fábrega E; Carte B; Pons-Romero F
Med Clin (Barc); 1996 Feb; 106(7):241-5. PubMed ID: 8667672
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of hepatitis-C virus infection in children with chronic post-transfusion hepatitis.
Puchhammer-Stöckl E; Hofmann H; Fink FM; Mor W; Höcker-Schulz S; Heinz FX; Kunz C
J Med Virol; 1992 Aug; 37(4):298-302. PubMed ID: 1328503
[TBL] [Abstract][Full Text] [Related]
58. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
[TBL] [Abstract][Full Text] [Related]
59. Improved detection of hepatitis C virus RNA by reverse transcription and polymerase chain reaction.
Wolff C; Schlüter K; Prohaska W; Kleesiek K
Eur J Clin Chem Clin Biochem; 1992 Nov; 30(11):717-27. PubMed ID: 1283341
[TBL] [Abstract][Full Text] [Related]
60. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
